Cardiometabolic Risk Related to the Association of hypertriglyceridemia-Low HDLc

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|3|365-371

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.3, 2016-01, pp. : 365-371

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiometabolic risk factors in T2DM improved by rimonabant

By  

Inpharma, Vol. 1, Iss. 1655, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Insulin Resistance and Endothelial Dysfunction: A Mutual Relationship in Cardiometabolic Risk

By  

Current Pharmaceutical Design, Vol. 19, Iss. 13, 2013-04 ,pp. : 2420-2431

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of Tobacco Smoking on Lipid Metabolism, Body Weight and Cardiometabolic Risk

By  

Current Pharmaceutical Design, Vol. 16, Iss. 23, 2010-08 ,pp. : 2526-2530

Bentham Science Publishers

Access to resources Recommend Favorite

Association between Th17-related cytokines and risk of non–small cell lung cancer among patients with or without chronic obstructive pulmonary disease

By LiaoChen   YuZu-Bin   MengGang   WangLi   LiuQing-Yun   ChenLiu-Tong   FengShuang-Shuang   TuHong-Bo   LiYa-Fei   BaiLi  

Cancer, Vol. 121, Iss. 17, 2015-09 ,pp. : 3122-3129

Blackwell Publishing

Access to resources Recommend Favorite

Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study

By Florentin M   Liberopoulos EN   Filippatos TD   Kostara C   Tselepis A   Mikhailidis DP   Elisaf M  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2741-2750

Informa Healthcare

Access to resources Recommend Favorite